In addition, in this study the expression of HLA family members and several immunotherapy-related target genes, such as CD274 (PD-L1), CTLA-4, and LAG-3, was elevated in the tumor environment of the high-risk group compared with the low-risk group (Figures 6F, G). Here, LAG3 is linked to neoplasm.